Barclays Downgrades Exelon to Equal-Weight, Lowers Price Target to $49

Benzinga Newsdesk www.benzinga.com Negative 84.2%

Neg 84.2% Neu 0% Pos 0%

Barclays analyst Nicholas Campanella downgrades Exelon (NASDAQ:EXC) from Overweight to Equal-Weight and lowers the price target from $50 to $49.